// App-Quantinova.ai

11541 : Detection, frequency and actionability of recurrent copy number gains detected by non-invasive liquid biopsy of 3,942 lung and breast cancer samples.

Researchers

Presenter

  • Diana Abdueva

Principal Investigators

  • Darya Chudova

  • Richard Burnham Lanman

  • Kimberly C. Banks

  • Rebecca J Nagy

  • Stefanie Mortimer

  • Amirali Talasaz

  • Helmy Eltoukhy

  • Razelle Kurzrock

Medical Centers

  • Guardant Health, Rewdwood City, CA

  • Guardant Health, Rewdwood City, CA

  • University of California, San Diego, La Jolla, CA

Locations

  • United States

Companies

  • Guardant Health, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved